CompoAtlas

Max Creatine

Max Creatine, licence 80106406: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Nova 3 Labs
NPN or DIN-HM
80106406
Status
Active licence
Licence date
20 November 2020
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-(Aminoiminométhyl)-N-méthylglycine monohydraté

Source : Créatine monohydratée

1665.0 mgNot calculated
Pyruvate de créatine

Source : Pyruvate de créatine

1665.0 mgNot calculated
Citrate de tricréatine

Source : Tricreatine citrate

1665.0 mgNot calculated

Non-medicinal ingredients

Sucralose, Saveur

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)1.0 Portions1.0 Jour

Uses authorised in Canada

Text supplied in English because no French text is available.

Improves strength/power/performance in repetitive bouts of brief, highly-intense physical activity (e.g. sprints, jumping, resistance training) (by increasing [muscle/intramuscular] [creatine/phosphocreatine/energy] levels). Increases body/(lean)muscle mass/size when used in conjunction with a resistance training regimen.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80106406

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line